Business

5-star analyst resets Oracle stock price target

Oracle (ORCL) stock closed the June 2 trading session down 1.44% at $244.58. Despite this slight drop, the stock is now up about 25.48% year to date, at the time of writing, Wednesday morning, June 3.

Meanwhile, the SPDR S&P 500 Index (SPY) is up about 11.39% in the same period. Oracle has decently outpaced the S&P 500, but if we were looking at the stock's performance just a week ago, things would have been quite different.

If we go back to May 27, things get more interesting, as it closed at $190.96 on that date. This means it has soared about 28% in a week.

Investors are eagerly awaiting Oracle's fourth-quarter (Q4) fiscal year (FY) 2026 earnings report, set for June 10, and analysts are resetting their price targets.

Key news for Oracle stock:

 UBS raised Oracle stock price target. Shutterstock
UBS raised Oracle stock price target. Shutterstock

UBS raises Oracle stock price target

UBS analyst Karl Keirstead updated his opinion on Oracle ahead of the earnings report, according to Investing.

He is a 5-star-rated analyst with a 64% success rate and an average return of 15.0%, according to TipRanks.

Keirstead said that after receiving feedback from Oracle's four large customers, partners, and one contractor on the data center build-out at Abilene, Texas, he doesn't believe there has been any setback in momentum.

More tech stocks:

The analyst reiterated a buy rating for Oracle stock and raised the price target to $285 from $250, based on a 27x multiple of his calendar-year 2027 estimate for non-GAAP earnings per share. His price target implies an upside of 16.5% from the last closing price.

UBS isn't the only bank that raised its price target for Oracle ahead of earnings. Scotiabank reiterated an outperform (buy) rating and raised the price target to $290 from $215, according to TipRanks.

Of 42 analyst ratings, 32 rate Oracle a buy, nine rate it a hold, and one rates it a sell, with an average price target of $263.62, according to MarketBeat.

We can see that Keirstead is among the more bullish analysts on Oracle. We should also take a look at what analysts who aren't bullish think.

Morgan Stanley remains neutral on Oracle

In a research note shared with me from April 23, Morgan Stanley analyst Keith Weiss and his team updated their opinion on Oracle stock. The team hasn't issued any more updates since.

Analysts noted that Oracle's customer concentration is a key risk, but they believe recent data points and ecosystem developments are constructive.

Weiss reiterated an equal-weight (hold) rating for Oracle stock and lowered the price target to $207 from $213, based on a 25x multiple of his estimate for non-GAAP EPS for fiscal year 2028 of $8.28.

Along with the base case for Oracle's stock, Morgan Stanley's analysts also presented a bear case, with a price target of $75.00. They wrote: "Our bear case assumes Oracle below historical averages given lack of confidence towards accelerating EPS growth in the out years as [GPU-as-a-Service] opportunity falls meaningfully short of expectations."

Morgan Stanley analysts noted downside risks for Oracle stock:

  • Challenges in ramping up OCI capacity.
  • Weaker than expected OCI gross margins.
  • GPUaaS capacity investments drive substantial leverage.
  • Disruptive technologies in the data management market.

Upside potential for Oracle:

  • Faster than expected OCI capacity ramps.
  • Stronger than expected OCI gross margins.
  • Accelerated adoption of Fusion Apps and Cloud.
  • Database across the installed base.
  • Acceleratedmarket share gains in non-AI Cloud.

Related: Bank of America resets Nvidia stock forecast after key event

The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

This story was originally published June 3, 2026 at 12:13 PM.

Get one year of unlimited digital access for $159.99
#ReadLocal

Only 44¢ per day

SUBSCRIBE NOW